Fund Overview of HDFC Pharma And Healthcare Fund Regular - Idcw
-
₹1,936.0 CrAUM
-
₹17.42NAV
-
2.08%Expense Ratio
-
EquityFund Category
Returns of HDFC Pharma And Healthcare Fund Regular - Idcw
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | 1.22% | NA | 6.12% |
| 6 Months | 14.78% | NA | 12.92% |
| 1 Year | 6.22% | 6.22% | 6.04% |
| 2 Years | 72.55% | 31.36% | 24.93% |
Asset Allocation
equities
98.31%other assets or cash equivalents
1.69%HDFC Pharma And Healthcare Fund Regular - Idcw is one Equity mutual fund offered by HDFC Mutual Fund. Launched on 04 Oct 2023, the fund aims To generate long-term capital appreciation Investment predominantly in equity & equity related instruments of Pharma and healthcare companies. It manages assets worth ₹1,936.0 crore as on Thu Jul 31, 2025. The expense ratio stands at 2.08%. Fund Manager Manager Education Fund Manager Manager EducationAbout HDFC Pharma And Healthcare Fund Regular - Idcw
The portfolio allocation consists of 98.31% in equities, 1.69% in other assets or cash equivalents. Managed by Nikhil Mathur, it has delivered a return of 6.22% in the last year, a total return since inception of 30.98%.
Fund Details
|
|
Top Performing Mutual Funds
| Fund Names | AUM (Cr) | 1M | 3M | 1Yr | 3Yr | 5Yr |
|---|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | 0.21% | 0.48% | 9.03% | 28.99% | 21.62% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | 0.12% | 0.25% | 8.10% | 27.87% | 20.55% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | -0.03% | -1.35% | 5.10% | 23.18% | 17.50% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | -0.13% | -1.67% | 3.76% | 21.53% | 15.83% |
More funds from HDFC Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
HDFC Pharma And Healthcare Fund Regular - Growth
|
₹1,936 | 0.50% | 0.18% | 7.43% | 9.54% | - |
|
HDFC Pharma And Healthcare Fund Direct - Growth
|
₹1,936 | 0.60% | 0.48% | 8.07% | 10.85% | - |
|
HDFC Pharma And Healthcare Fund Direct - Idcw
|
₹1,936 | 0.60% | 0.48% | 8.07% | 10.85% | - |
Mutual Fund Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | ₹40.45 | 27.87% | 20.55% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | ₹43.71 | 28.99% | 21.62% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | ₹34.41 | 23.18% | 17.50% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | ₹31.21 | 21.53% | 15.83% | - |
| ICICI Prudential Nifty Healthcare Etf - Growth |
₹146 | ₹152.37 | 22.80% | - | - |
| Aditya Birla Sun Life Nifty Healthcare Etf-growth |
₹37 | ₹15.28 | 22.97% | - | - |
Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.97% | ₹212.42 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.70% | ₹210.43 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.70% | ₹210.43 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.47% | ₹198.43 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.87% | ₹174.55 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.87% | ₹174.55 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.81% | ₹170.49 Cr |
| Divi's Laboratories Ltd | Healthcare | 7.76% | ₹147.07 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 7.42% | ₹143.58 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 6.93% | ₹131.38 Cr |
| Lupin Ltd | Healthcare | 6.67% | ₹131.12 Cr |
| Lupin Ltd | Healthcare | 6.67% | ₹131.12 Cr |
| Lupin Ltd | Healthcare | 6.84% | ₹129.64 Cr |
| Cipla Ltd | Healthcare | 6.33% | ₹122.56 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 6.05% | ₹118.93 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 6.05% | ₹118.93 Cr |
| Lupin Ltd | Healthcare | 5.98% | ₹115.69 Cr |
| Alkem Laboratories Ltd | Healthcare | 5.83% | ₹114.70 Cr |
| Alkem Laboratories Ltd | Healthcare | 5.83% | ₹114.70 Cr |
| Alkem Laboratories Ltd | Healthcare | 5.94% | ₹112.58 Cr |
| Max Healthcare Institute Ltd | Healthcare | 5.49% | ₹107.89 Cr |
| Max Healthcare Institute Ltd | Healthcare | 5.49% | ₹107.89 Cr |
| Max Healthcare Institute Ltd | Healthcare | 4.66% | ₹88.28 Cr |
| Ipca Laboratories Ltd | Healthcare | 4.50% | ₹85.33 Cr |
| Ipca Laboratories Ltd | Healthcare | 4.37% | ₹84.67 Cr |
| Cipla Ltd | Healthcare | 4.32% | ₹81.83 Cr |
| Ipca Laboratories Ltd | Healthcare | 4.12% | ₹81.01 Cr |
| Ipca Laboratories Ltd | Healthcare | 4.12% | ₹81.01 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.88% | ₹75.06 Cr |
| Laurus Labs Ltd | Healthcare | 3.80% | ₹74.70 Cr |
| Laurus Labs Ltd | Healthcare | 3.80% | ₹74.70 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.82% | ₹73.97 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 3.71% | ₹72.89 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 3.71% | ₹72.89 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.81% | ₹72.28 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.63% | ₹71.41 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.63% | ₹71.41 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.61% | ₹71.00 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.61% | ₹71.00 Cr |
| Laurus Labs Ltd | Healthcare | 3.64% | ₹70.50 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.64% | ₹68.94 Cr |
| Anthem Biosciences Ltd. | Healthcare | 3.50% | ₹68.81 Cr |
| Anthem Biosciences Ltd. | Healthcare | 3.50% | ₹68.81 Cr |
| Eris Lifesciences Ltd | Healthcare | 3.55% | ₹68.66 Cr |
| Laurus Labs Ltd | Healthcare | 3.58% | ₹67.88 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 3.55% | ₹67.40 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 3.36% | ₹65.03 Cr |
| Anthem Biosciences Ltd. | Healthcare | 3.26% | ₹61.72 Cr |
| Eris Lifesciences Ltd | Healthcare | 3.19% | ₹60.53 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.99% | ₹57.94 Cr |
| Anthem Biosciences Ltd. | Healthcare | 2.96% | ₹57.33 Cr |
| Cipla Ltd | Healthcare | 2.89% | ₹56.88 Cr |
| Cipla Ltd | Healthcare | 2.89% | ₹56.88 Cr |
| Eris Lifesciences Ltd | Healthcare | 2.88% | ₹56.69 Cr |
| Eris Lifesciences Ltd | Healthcare | 2.88% | ₹56.69 Cr |
| Ami Organics Ltd | Healthcare | 2.86% | ₹56.15 Cr |
| Ami Organics Ltd | Healthcare | 2.86% | ₹56.15 Cr |
| Metropolis Healthcare Ltd | Healthcare | 2.64% | ₹50.04 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 2.58% | ₹49.89 Cr |
| Metropolis Healthcare Ltd | Healthcare | 2.53% | ₹49.04 Cr |
| Metropolis Healthcare Ltd | Healthcare | 2.46% | ₹48.43 Cr |
| Metropolis Healthcare Ltd | Healthcare | 2.46% | ₹48.43 Cr |
| Gland Pharma Ltd | Healthcare | 2.49% | ₹48.12 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 2.45% | ₹46.41 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 2.33% | ₹45.88 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 2.33% | ₹45.88 Cr |
| Ami Organics Ltd | Healthcare | 2.27% | ₹44.04 Cr |
| Ami Organics Ltd | Healthcare | 2.31% | ₹43.72 Cr |
| Wockhardt Ltd | Healthcare | 2.22% | ₹43.07 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 2.21% | ₹42.78 Cr |
| Repo | Unspecified | 2.09% | ₹40.43 Cr |
| Gland Pharma Ltd | Healthcare | 2.12% | ₹40.24 Cr |
| Max Healthcare Institute Ltd | Healthcare | 2.07% | ₹40.16 Cr |
| Wockhardt Ltd | Healthcare | 2.07% | ₹39.16 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.99% | ₹37.67 Cr |
| Repo | Unspecified | 1.91% | ₹37.54 Cr |
| Repo | Unspecified | 1.91% | ₹37.54 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 1.92% | ₹37.18 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 1.88% | ₹36.99 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 1.88% | ₹36.99 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 1.94% | ₹36.79 Cr |
| Fortis Healthcare Ltd | Healthcare | 1.89% | ₹35.80 Cr |
| Jubilant Pharmova Ltd | Healthcare | 1.78% | ₹34.96 Cr |
| Jubilant Pharmova Ltd | Healthcare | 1.78% | ₹34.96 Cr |
| Piramal Pharma Ltd | Healthcare | 1.79% | ₹34.57 Cr |
| Jubilant Pharmova Ltd | Healthcare | 1.81% | ₹34.28 Cr |
| Piramal Pharma Ltd | Healthcare | 1.79% | ₹33.88 Cr |
| Sai Life Sciences Ltd. | Healthcare | 1.72% | ₹33.80 Cr |
| Sai Life Sciences Ltd. | Healthcare | 1.72% | ₹33.80 Cr |
| Fortis Healthcare Ltd | Healthcare | 1.73% | ₹33.54 Cr |
| Jubilant Pharmova Ltd | Healthcare | 1.73% | ₹33.44 Cr |
| Wockhardt Ltd | Healthcare | 1.68% | ₹33.10 Cr |
| Wockhardt Ltd | Healthcare | 1.68% | ₹33.10 Cr |
| Sai Life Sciences Ltd. | Healthcare | 1.67% | ₹31.68 Cr |
| Thyrocare Technologies Ltd | Healthcare | 1.58% | ₹31.17 Cr |
| Thyrocare Technologies Ltd | Healthcare | 1.58% | ₹31.17 Cr |
| Sai Life Sciences Ltd. | Healthcare | 1.54% | ₹29.76 Cr |
| Piramal Pharma Ltd | Healthcare | 1.50% | ₹29.45 Cr |
| Piramal Pharma Ltd | Healthcare | 1.50% | ₹29.45 Cr |
| Laxmi Dental Ltd. | Healthcare | 1.40% | ₹27.20 Cr |
| Bajaj Healthcare Ltd | Healthcare | 1.32% | ₹25.52 Cr |
| Bajaj Healthcare Ltd | Healthcare | 1.34% | ₹25.48 Cr |
| Pfizer Ltd | Healthcare | 1.29% | ₹25.29 Cr |
| Pfizer Ltd | Healthcare | 1.29% | ₹25.29 Cr |
| Gland Pharma Ltd | Healthcare | 1.29% | ₹25.28 Cr |
| Gland Pharma Ltd | Healthcare | 1.29% | ₹25.28 Cr |
| Pfizer Ltd | Healthcare | 1.30% | ₹25.22 Cr |
| Bajaj Healthcare Ltd | Healthcare | 1.27% | ₹24.95 Cr |
| Bajaj Healthcare Ltd | Healthcare | 1.27% | ₹24.95 Cr |
| Pfizer Ltd | Healthcare | 1.29% | ₹24.45 Cr |
| Laxmi Dental Ltd. | Healthcare | 1.11% | ₹20.96 Cr |
| Ajanta Pharma Ltd | Healthcare | 1.05% | ₹20.66 Cr |
| Ajanta Pharma Ltd | Healthcare | 1.05% | ₹20.66 Cr |
| Laxmi Dental Ltd. | Healthcare | 1.03% | ₹20.25 Cr |
| Laxmi Dental Ltd. | Healthcare | 1.03% | ₹20.25 Cr |
| Repo | Unspecified | 1.05% | ₹19.84 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.02% | ₹19.82 Cr |
| Rubicon Research Ltd. | 1.00% | ₹19.61 Cr | |
| Rubicon Research Ltd. | 1.00% | ₹19.61 Cr | |
| Fortis Healthcare Ltd | Healthcare | 0.95% | ₹18.64 Cr |
| Fortis Healthcare Ltd | Healthcare | 0.95% | ₹18.64 Cr |
| Shilpa Medicare Ltd | Healthcare | 0.89% | ₹17.43 Cr |
| Shilpa Medicare Ltd | Healthcare | 0.89% | ₹17.43 Cr |
| Ajanta Pharma Ltd | Healthcare | 0.14% | ₹2.74 Cr |
| Net Payables | Unspecified | -0.06% | ₹-0.30 Cr |
| Net Payables | Unspecified | -0.22% | ₹-3.85 Cr |
| Net Payables | Unspecified | -0.22% | ₹-3.85 Cr |
| Net Payables | Unspecified | -0.29% | ₹-5.64 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹43.71 | 28.99% | 21.62% | 44.69 |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹40.45 | 27.87% | 20.55% | 41.47 |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹34.41 | 23.18% | 17.50% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹31.21 | 21.53% | 15.83% | - |
HDFC Pharma And Healthcare Fund Regular - Idcw
What is the current AUM of HDFC Pharma And Healthcare Fund Regular - Idcw?
As of Thu Jul 31, 2025, HDFC Pharma And Healthcare Fund Regular - Idcw manages assets worth ₹1,936.0 crore
How has HDFC Pharma And Healthcare Fund Regular - Idcw performed recently?
- 3 Months: 1.22%
- 6 Months: 14.78%
What is the long-term performance of HDFC Pharma And Healthcare Fund Regular - Idcw?
- Since Inception: 30.98%
What is the portfolio composition of HDFC Pharma And Healthcare Fund Regular - Idcw?
Equity: 98.31%, Others: 1.69%.
Who manages HDFC Pharma And Healthcare Fund Regular - Idcw?
HDFC Pharma And Healthcare Fund Regular - Idcw is managed by Nikhil Mathur from HDFC Mutual Fund.
What is the market-cap allocation of HDFC Pharma And Healthcare Fund Regular - Idcw?
Large Cap: 38.91%, Mid Cap: 25.73%, Small Cap: 35.36%.
Which are the top companies HDFC Pharma And Healthcare Fund Regular - Idcw has invested in?
- Sun Pharmaceutical Industries Ltd – 10.97% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 10.70% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 10.70% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 10.47% of the fund's portfolio
- Divi's Laboratories Ltd – 8.87% of the fund's portfolio
Which are the major sectors HDFC Pharma And Healthcare Fund Regular - Idcw focuses on?
- Healthcare – 390.81% of the fund's portfolio
- Unspecified – 6.17% of the fund's portfolio
- – 2.00% of the fund's portfolio
- Industrials – 1.02% of the fund's portfolio
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.


